NATCO Pharma recalls
FDA enforcement reports naming NATCO Pharma Limited as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Apr 17, 2024
- Apr 17, 2024Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent…Drug · NATCO Pharma LimitedCGMP DeviationsClass II
- Feb 14, 2024Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Nat…Drug · NATCO Pharma LimitedCGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.Class II